ALB and Alzheimer disease: Considering this idea, it is important to point out that several previous studies have shown altered BBB barrier function (demonstrated by analysis of different variables including Q-albumin [4, 26], CSF levels of fibrinogen as well as postmortem immunohistological stainings against BBB markers) in AD patients.